Work

Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor

Year: 2005

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1016/j.clpt.2005.06.011

Authors: D KUBITZA, M BECKA, B VOITH, M ZUEHLSDORF, G WENSING

Institution: Bayer (Germany)

Language: English

Topic: Blood Coagulation and Thrombosis Mechanisms

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2045987573

FWCI: 9.581

Cites: 30

Cited by: 652

Related to: 10